Literature DB >> 8236164

Molecular cloning of the mouse equivalent of CD9 antigen.

E Rubinstein1, M Billard, S Plaisance, M Prenant, C Boucheix.   

Abstract

The CD9 antigen was originally described as a 24 kDa molecule present on B lineage-derived acute lymphoblastic leukemia cells and developing B-lymphocytes. However, platelets express a large amount of CD9 antigen and can be activated by CD9 antibodies. We report here the cloning and sequencing of a cDNA coding for the mouse CD9 antigen. There is 89% homology at amino acid level between the human and mouse CD9 molecules. Most of the differences (19 out of 24) are located in the large putative extracellular domain encoded by exons 5 and 6. CD9 antigen belongs to a new cell surface protein family which includes TAPA1 and the platelet activation antigen CD63. These proteins share common structural features with the CD9 antigen and a similar distribution of the evolutionarily variable region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236164     DOI: 10.1016/0049-3848(93)90162-h

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Mapping of the genes for four members of the transmembrane 4 superfamily: mouse Cd9, Cd63, Cd81, and Cd82.

Authors:  M F Seldin; J M Rochelle; M G Tomlinson; M D Wright
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Expression and distribution of CD9 in myelin of the central and peripheral nervous systems.

Authors:  Y Nakamura; R Iwamoto; E Mekada
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  A role for CD9 molecules in T cell activation.

Authors:  X G Tai; Y Yashiro; R Abe; K Toyooka; C R Wood; J Morris; A Long; S Ono; M Kobayashi; T Hamaoka; S Neben; H Fujiwara
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

4.  A scalable approach to prevent teratoma formation of human embryonic stem cells.

Authors:  Zhili Rong; Xuemei Fu; Meiyan Wang; Yang Xu
Journal:  J Biol Chem       Date:  2012-08-04       Impact factor: 5.157

Review 5.  CD9, a tetraspanin target for cancer therapy?

Authors:  Aurelio Lorico; Marco Lorico-Rappa; Jana Karbanová; Denis Corbeil; Giuseppe Pizzorno
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-18

6.  Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.

Authors:  Swetha S D Peddibhotla; Benjamin F Brinkmann; Daniel Kummer; Hüseyin Tuncay; Masanori Nakayama; Ralf H Adams; Volker Gerke; Klaus Ebnet
Journal:  Mol Biol Cell       Date:  2013-02-06       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.